Aside from these observations, it has recently been reported that high expression of LncRNA FOXD2-AS1, which targets the LRP6 inhibitor DKK1 mRNA, predicts poor prognosis in HCC patients. The gene discussed is FOXD2; the disease is hepatocellular carcinoma.